Paliperidon Tad (Paliperidone)

Paliperidone, the active ingredient in Paliperidon Tad, is an atypical antipsychotic presented as an oral tablet for oral use. It is prescribed for the management of schizophrenia and related psychotic disorders in adults. GNH USA supplies Paliperidon Tad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paliperidon Tad is used in psychiatric care to address dopamine‑related disorders. - Schizophrenia: reduces positive and negative psychotic symptoms and helps prevent relapse. - Schizoaffective disorder: stabilises mood swings while controlling psychotic features. - Maintenance therapy for chronic schizophrenia: maintains symptom control over the long term.

Paliperidon Tad may cause a range of adverse reactions.

Common Side Effects: - Weight gain: increase in body mass during treatment. - Somnolence: feeling unusually sleepy or fatigued. - Extrapyramidal symptoms: muscle stiffness, tremor, or restlessness. - Dizziness: light‑headedness, especially when standing. - Constipation: reduced bowel movements. - Dry mouth: decreased salivation.

Serious or Rare Side Effects: - Tardive dyskinesia: involuntary, repetitive movements. - Neuroleptic malignant syndrome: life‑threatening fever and muscle rigidity. - Hyperglycemia: elevated blood sugar levels. - Orthostatic hypotension: significant drop in blood pressure upon standing. - Seizures: risk of convulsive episodes. - Agranulocytosis: severe reduction in white blood cells.

Before initiating therapy with Paliperidon Tad, consider the following safety measures. - Pregnancy: avoid use unless clearly needed; discuss risks with a healthcare professional. - Breastfeeding: not recommended as the drug passes into milk. - Cardiovascular: monitor blood pressure and heart rate regularly. - Metabolic: assess glucose and lipid levels periodically. - CNS disorders: use caution in patients with a history of seizures. - Drug interactions: review concomitant medications for potential interactions. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Paliperidon Tad can interact with several drug classes.

Major Interactions (Avoid): - CYP2D6 inhibitors: may increase paliperidone plasma concentrations. - CNS depressants: additive sedation and respiratory depression. - QT‑prolonging agents: heightened risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely):\n- Antihypertensives: possible enhancement of hypotensive effects. - Anticholinergics: may mask anticholinergic side effects. - CYP3A4 inducers: could reduce paliperidone efficacy. - Alcohol: may intensify central nervous system depression. - NSAIDs: increase risk of gastrointestinal bleeding.